Código QR (código de barras bidimensional)

Pretreatment clinical and hematological predictors of efficacy and immune-related adverse events in patients with advanced non-small cell lung cancer receiving first-line chemotherapy combined with immune checkpoint inhibitors

Abstract Background The combination of immune checkpoint inhibitors (ICI) and platinum-based chemotherapy has rapidly become the standard first-line treatment for advanced or metastatic non-small cell lung cancer (NSCLC). However, identifying reliable predictive factors of treatment response remains...

Fuld beskrivelse

Na minha lista:
Principais autores: Shun Matsuura, Kensuke Kita, Kyohei Matsushita, Takumi Nagasaki, Ryo Suzuki, Yuya Yamamoto, Kotaro Yamada, Ryuuichi Nakamura, Norimichi Akiyama, Kazuki Tanaka, Naoki Koshimizu
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2026-02-01
Serier:BMC Cancer
Fag:
Advanced non-small cell lung carcinoma
ECOG-PS
Number of metastases
Immune-related adverse events
Online adgang:https://doi.org/10.1186/s12885-026-15733-9
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker